|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
|
|
|
|
|
|
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
A Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel-Trenaunay Syndrome - A Prospective Natural History Study of Patients with Intractable Venous Malformation and Klippel-Trenaunay Syndrome
A Phase 1 study to evaluate the safety, tolerability and pharmacokinetics of single and repeated doses of ART-001 in healthy Japanese male volunteers
A pathogenic mosaic mutation analysis of the Japanese patients with vascular malformations - A mutation analysis of vascular malformations
100 项与 ARTham Therapeutics, Inc. 相关的临床结果
0 项与 ARTham Therapeutics, Inc. 相关的专利(医药)
100 项与 ARTham Therapeutics, Inc. 相关的药物交易
100 项与 ARTham Therapeutics, Inc. 相关的转化医学